DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company. This injunction results from a lawsuit filed by Covidien in June 2014 that alleges Ethicon’s latest ultrasonic surgical product, the Harmonic ACE®+7, infringes three Covidien patents. The injunction prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE®+7.
“Covidien operates within a highly competitive global health care environment. We are pleased that the court has recognized the value of our intellectual property. As demonstrated by our actions, we will vigorously protect our innovative products, solutions and intellectual property,” said Chris Barry, president, Advanced Surgical, Covidien.
Help employers find you! Check out all the jobs and post your resume.
